Lastly, Dr. Clark Chen, Director of Stereotactic and Radiosurgery and Vice-Chairman of Academic Affairs at the University Of California San Diego Department Of Neurosurgery, presented two posters on data from Monteris Medical’s prospective multi-center registry (LAANTERN). The posters titled “Laser Ablation of Abnormal Neurological Tissue using Robotic NeuroBlate System (LAANTERN): Procedural Safety and Hospitalization” and “Clinical Utilization of Stereotactic Laser Ablation (SLA): an Analysis of the Multi-center Prospective Registry, LAANTERN” provide initial data on the first 50 patients enrolled in this ongoing study.
“The data presented at the AANS Annual Meeting supports NeuroBlate’s potential in addressing brain lesions that historically have not responded well to standard interventions,” said Daryle Petersen, Vice President of Clinical Affairs at Monteris Medical. “We are excited to present our first data extract from LAANTERN, our ongoing multi-center prospective registry on laser ablation. Open, frequent communications are vital to the success of any registry and we look forward to sharing results on this novel, minimally invasive technology at future meetings.”
Ad Statistics
Times Displayed: 62296
Times Visited: 2040 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About the NeuroBlate® System
The NeuroBlate System is indicated for use to ablate, necrotize or coagulate soft tissue encountered in the discipline of neurosurgery through the application of laser thermotherapy. NeuroBlate is a tool (as opposed to a “treatment”) and is not intended to treat any specific disease. Physicians should use their clinical judgment and experience when deciding whether to use NeuroBlate.
Monteris Medical’s LITT technology, including NeuroBlate and its predecessor AutoLITT, has been used in more than 1,250 patient procedures across 46 installed systems in the U.S. and Canada.
Full prescribing information for the NeuroBlate System is available at www.monteris.com.
About Monteris
Monteris® Medical is a privately held company developing innovative MRI-guided, laser-based brain lesion therapy. Monteris Medical markets the NeuroBlate® System, a neurosurgical ablation device providing controlled therapy for brain lesions. The company also offers the Monteris Mini-Bolt, the only cranial bolt system that enables a robotic interface for protected and precise therapy delivery, as well as the AtamA™ Stabilization System for MRI-guided neurosurgical procedures requiring head fixation.
For more information on Monteris Medical please visit www.monteris.com.
Back to HCB News
